STAGE IIIC NON-SMALL CELL LUNG CANCER
Clinical trials for STAGE IIIC NON-SMALL CELL LUNG CANCER explained in plain language.
Never miss a new study
Get alerted when new STAGE IIIC NON-SMALL CELL LUNG CANCER trials appear
Sign up with your email to follow new studies for STAGE IIIC NON-SMALL CELL LUNG CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New combo therapy shows promise for Hard-to-Treat lung cancer
Disease control CompletedThis early-phase study tested a new drug called ONO-7475 combined with the standard targeted therapy osimertinib in 78 people with advanced EGFR-mutated non-small cell lung cancer. The goal was to see if the combination is safe and tolerable. Participants had stage IIIB, IIIC, IV…
Matched conditions: STAGE IIIC NON-SMALL CELL LUNG CANCER
Phase: PHASE1 • Sponsor: Ono Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Jun 18, 2026 11:52 UTC
-
Precision radiation combo shows promise for tough lung cancers
Disease control CompletedThis study tested a new way to treat advanced lung cancer (stages IIB to IIIC) that cannot be removed by surgery. It combined MRI-guided radiation with chemotherapy and an immunotherapy drug called durvalumab. The goal was to see if this approach is safe and helps control the can…
Matched conditions: STAGE IIIC NON-SMALL CELL LUNG CANCER
Phase: PHASE2 • Sponsor: Washington University School of Medicine • Aim: Disease control
Last updated Jun 16, 2026 12:50 UTC